{
  "nct_id": "NCT00454363",
  "study_title": "Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer",
  "search_date": "2025-07-15T13:49:28.962178",
  "publications_found": 1,
  "publications": [
    {
      "pmid": "25956795",
      "title": "Phan AT, Halperin DM, Chan JA, Fogelman DR, Hess KR, Malinowski P, Regan E, Ng CS, Yao JC, Kulke MH....",
      "authors": [],
      "journal": "From Clinical Trial Data",
      "year": "N/A",
      "doi": null,
      "abstract": "Phan AT, Halperin DM, Chan JA, Fogelman DR, Hess KR, Malinowski P, Regan E, Ng CS, Yao JC, Kulke MH. Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study. Lancet Oncol. 2015 Jun;16(6):695-703. doi: 10.1016/S1470-2045(15)70136-1. Epub 2015 May 5.",
      "url": "https://pubmed.ncbi.nlm.nih.gov/25956795/",
      "source": "study_data"
    }
  ]
}